Advances in Clinical and Experimental Medicine

Title abbreviation: Adv Clin Exp Med
JCR Impact Factor (IF) – 2.1 (5-Year IF – 2.0)
Journal Citation Indicator (JCI) (2023) – 0.4
Scopus CiteScore – 3.7 (CiteScore Tracker 3.3)
Index Copernicus  – 161.11; MNiSW – 70 pts

ISSN 1899–5276 (print)
ISSN 2451-2680 (online)
Periodicity – monthly

Download whole issue [PDF]

Contents – 2023, Vol. 32, No. 5 (May)

1

Editorial

Preclinical modeling in depression and anxiety: Current challenges and future research directions

505-509

2

Meta-analysis

Meta-analysis on the efficacy of the norepinephrine reuptake inhibitors reboxetine and atomoxetine for the treatment of schizophrenia and attention deficit hyperactivity disorder

511-522

3

Meta-analysis

Complications of implanted port catheters and peripherally inserted central catheters in chemotherapy-treated cancer patients: A meta-analysis

523-532

4

Original Article

Effects of arthroscopic anterior cruciate ligament reconstruction combined with sodium hyaluronate on knee function and inflammatory markers in anterior cruciate ligament injury patients with or without knee osteoarthritis

533-538

5

Original Article

Differential expression of miRNAs from extracellular vesicles in chronic graft-versus-host disease: A preliminary study

539-544

6

Original Article

The role of serum nesfatin-1 in a rat model of acute pancreatitis

545-549

7

Original Article

Bone marrow mesenchymal stem cell-derived exosomes attenuate the maturation of dendritic cells and reduce the rejection of allogeneic transplantation

551-561

8

Original Article

Establishment of a mouse model of inflammatory bowel disease using dextran sulfate sodium

563-573

9

Original Article

miR-29a-5p regulates the malignant biological process of liver cancer cells through ARID2 regulation of EMT

575-582

10

Original Article

Hepatitis B virus X protein induces p16 gene promoter methylation through upregulation of DNA methylation transferases DNMT1 and DNMT3A

583-592

11

Original Article

hsa_circ_0038382 upregulates T-box transcription factor 5 to inhibit keloid formation by interacting with miR-940

593-601